Diversified Energy Company appoints Randall Wade as new Independent NED

Diversified Energy Company (LON:DEC) enhances its leadership by appointing Randall Wade as an independent non-executive director, effective April 11, 2025...

Cerillion confident on outlook with strong pipeline

Cerillion plc announces projected first-half revenue of £20.9m, reflecting a shift in software license renewals. Strong customer pipeline signals growth ahead...

Dr Mathews Phosa named Jubilee Metals’ new Chairperson

Jubilee Metals Group announces leadership changes as Ollie Oliveira retires as chairperson, with Dr. Mathews Phosa stepping in, ensuring continuity in governance...

Hercules Site Services joins Wessex Water’s new Civils Support Framework

Hercules Site Services plc secures a key role in Wessex Water's Civils Support Framework, enhancing construction support for vital infrastructure projects...

CyanConnode wins £70m smart meter contract in Goa

CyanConnode Holdings' subsidiary, DigiSmart Networks, secures a £70 million smart metering contract in Goa, marking a pivotal milestone for its expansion in India...

EDX Medical Group to launch highly accurate early detection test for testicular cancer

EDX Medical Group is set to launch TC100, a groundbreaking early detection test for testicular cancer in the UK, offering unparalleled accuracy for improved patient care...

Optima Health expands into Ireland with Cognate Health acquisition

Optima Health Plc has announced its acquisition of Cognate Health Limited for up to €9 million, expanding its footprint in the Irish occupational health sector...

Drax Pumped Storage Hydro: Powering a Resilient, Low-Carbon Grid

Drax Group plc (LON:DRX) continues to move forward in the renewable energy sector, particularly through its advancements in pumped storage hydro technology...

hVIVO delivers record 2024 results, revenue up 11.9% and EBITDA up 25.9%

hVIVO plc reports impressive audited results for 2024, showcasing a revenue increase and strong EBITDA growth in the human challenge clinical trial sector...

Norcros reports strong results and strategic resilience amid global uncertainty

Norcros plc is set to announce its full-year results for the year ending March 31, 2025, on June 12, 2025, highlighting strong profitability and growth trends...

Croda International Plc Q1 sales up 8%, outlook unchanged

Croda International Plc reports an 8% sales increase to £442m in Q1 2025, driven by growth across Life Sciences, Consumer Care, and Industrial Specialties...

Fresnillo maintains 2025 guidance amid lower silver output

Fresnillo plc (LON:FRES) reports stable Q1 production, highlighting changes in silver and gold output while maintaining strong operational plans for 2025...

FTSE 100 defies global market turmoil with strategic gains

In a volatile global market, the UK's FTSE 100 stands out, rising 0.3% amid positive economic signals and sector strength, highlighting its resilience...

DCC Plc to sell healthcare unit for £1.05 billion

DCC plc has agreed to sell its healthcare division to HealthCo Investment for £1.05 billion, streamlining operations and enhancing shareholder value...

AstraZeneca Plc Enhertu trial hits key PFS goal

The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...

GSK Plc’s Penmenvy vaccine backed by US Advisory Panel

GSK's Penmenvy vaccine is set to transform adolescent immunisation against meningococcal disease in the US, streamlining protection with fewer doses...

Trainline Plc reports record FY25 results

Trainline plc (LON:TRN) reports impressive FY2025 results, showcasing record ticket sales and growth in Europe’s leading rail app, driven by digital innovation...

RHI Magnesita reports challenging start to Q1, FY guidance maintained

RHI Magnesita N.V. shares updated trading insights for Q1 2025, highlighting increased risks due to weak performance and rising global trade tensions...

Syncona’s Beacon reports positive 6-month data from XLRP trial

Syncona Ltd's portfolio company, Beacon Therapeutics, reveals promising Phase II DAWN trial results for laru-zova, targeting X-linked retinitis pigmentosa (XLRP)...

Dunelm Group Plc appoints Katharine Poulter as Non-Executive Director

Dunelm Group Plc has appointed Katharine Poulter as Non-Executive Director, enhancing its board with her extensive retail experience and strategic expertise...

ZIGUP Plc wins King’s Award for Enterprise in Promoting Opportunity

ZIGUP Plc has earned the prestigious King's Award for Enterprise, celebrating its commitment to promoting opportunity and supporting disadvantaged individuals in the workforce...

Rotork Plc reports order growth, strategy progress and £44m acquisition

Rotork plc (LON:ROR) reports strong Q1 2025 trading growth, highlighting order increases across divisions and successful strategic initiatives ahead of its AGM...

AIM All Share Index

Trending Articles

Search

Search

Currency